Skip to main content

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

By CNBC
| November 12, 2021

Healthcare conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its pharmaceutical and medical device operations, creating two publicly traded companies. The news sent shares higher in premarket trading.

Tagged Under:

business strategy

View the discussion thread.

Most Popular

#1

The signs patients have the delta variant are different than original COVID-19

Cough, fever, and shortness of breath are common COVID-19 symptoms. Sinus congestion, runny nose and sore throat are symptoms of becoming infected with the delta variant. Sneezing more than usual...

#2

'COVID arm' rash seen after Moderna vaccine annoying but harmless, doctors say

An angry red rash being called “COVID arm” is a harmless but annoying response in some people who get the Moderna vaccine. Aside from sometimes being itchy, it doesn't appear to be dangerous, and...

#3

CMS Expands Medicare Coverage for Remote Patient Monitoring

The Centers for Medicare & Medicaid Services has added new codes to its 2022 Physician Fee Schedule that will enable care providers to be reimbursed for more home-based services. ...

#4

CDC Announces New ICD-10-CM Codes for COVID-19-related Conditions

All six new codes will be effective January 1, 2021. ...

#5

ECMO Life Support 'Last-Ditch' Intervention for Coronavirus Patients

Extracorporeal membrane oxygenation provides life support for coronavirus patients suffering respiratory failure. ...